Provided by Tiger Trade Technology Pte. Ltd.

Co-Diagnostics, Inc.

1.11
-0.0112-1.00%
Volume:36.01K
Turnover:39.75K
Market Cap:7.74M
PE:-0.05
High:1.12
Open:1.10
Low:1.09
Close:1.12
52wk High:46.50
52wk Low:0.9396
Shares:6.98M
Float Shares:6.86M
Volume Ratio:1.31
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-23.8424
EPS(LYR):-37.2229
ROE:-174.77%
ROA:-59.63%
PB:0.61
PE(LYR):-0.03

Loading ...

Co-Diagnostics Q2 EPS Usd -1.46

THOMSON REUTERS
·
Aug 14

Co-Diagnostics Inc Expected to Post a Loss of $3.00 a Share - Earnings Preview

Reuters
·
Aug 12

Co-Diagnostics Submits FDA 510(k) Filing for Flu A/B and RSV Point-of-Care Test

Reuters
·
Aug 06

Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test

THOMSON REUTERS
·
Aug 06

Co-Diagnostics Holders Exercise 1,702,362 Warrants at USD 1.57 Per Share in Inducement Deal

Reuters
·
Jul 31

Co-Diagnostics Schedules Q2 2026 Earnings Release and Webcast

Reuters
·
Jul 30

Co-Diagnostics Affiliate CoSara Sends Saragene Bundibugyo Ebola Test Kits for Third-party Evaluation

Reuters
·
Jul 28

Co-Diagnostics - Amends Equity Distribution Agreement with Maxim Group for Common Stock Sale - SEC Filing

THOMSON REUTERS
·
Jul 28

Co-Diagnostics Amends Maxim Equity Distribution Agreement, Removes Aggregate Sales Cap

Reuters
·
Jul 28

Co-Diagnostics' India Joint Venture Launches Clinical Studies for Tuberculosis Test

MT Newswires Live
·
Jul 22

Co-diagnostics - Co-dx Pcr Platform Products to be Manufactured and Distributed in India Under Cosara Brand

THOMSON REUTERS
·
Jul 22

Co-diagnostics Joint Venture Cosara Initiates Clinical Studies in India for Tuberculosis Test on Pcr Platform

THOMSON REUTERS
·
Jul 22

Co-diagnostics Announces Annual Shareholder Meeting

Reuters
·
Jul 21

Co-diagnostics Names Wes Lindsey Chief Scientific Officer

Reuters
·
Jul 16

Co-diagnostics Appoints Wes Lindsey, Phd, MBA as Chief Scientific Officer

THOMSON REUTERS
·
Jul 16

Co-diagnostics Announces Annual Shareholder Meeting

Reuters
·
Jul 10

NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am

Reuters
·
Jul 01

Co-diagnostics Completes Studies Ahead of Planned Q3 2026 FDA Filing for Flu/rsv Point-of-care PCR Test

Reuters
·
Jul 01

Co-diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-care Test

THOMSON REUTERS
·
Jul 01

Co-Diagnostics hosts Saudi joint venture CoMira for automated manufacturing line unveiling in Utah

Reuters
·
Jun 18